Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Researchers Report Potential Healthcare Cost Savings from Using Diachrome® as a Medical Nutrition Therapy for Type 2 Diabetes
Initial results of an economic analysis conducted by Thomas Jefferson University’s Department of Health Policy indicate that use of Diachrome® as an adjunct nutritional therapy for people with type 2 diabetes, could offer significant healthcare cost savings.
- Researchers Report Potential Healthcare Cost Savings from Using Diachrome® as a Medical Nutrition Therapy for Type 2 Diabetes
Initial results of an economic analysis conducted by Thomas Jefferson University’s Department of Health Policy indicate that use of Diachrome® as an adjunct nutritional therapy for people with type 2 diabetes, could offer significant healthcare cost savings.
- Congress Encourages Research on Chromium Picolinate and Diabetes
Bill signed into law by includes Report Language that recognizes that “chromium picolinate can restore normal glucose metabolism by enhancing insulin sensitivity,” and encourages NCCAM to expand its chromium research program.
- Congress Encourages Research on Chromium Picolinate and Diabetes
Bill signed into law by includes Report Language that recognizes that “chromium picolinate can restore normal glucose metabolism by enhancing insulin sensitivity,” and encourages NCCAM to expand its chromium research program.
- Congress Encourages Research on Chromium Picolinate and Diabetes
Bill signed into law by includes Report Language that recognizes that “chromium picolinate can restore normal glucose metabolism by enhancing insulin sensitivity,” and encourages NCCAM to expand its chromium research program.
- Congress Encourages Research on Chromium Picolinate and Diabetes
Bill signed into law by includes Report Language that recognizes that “chromium picolinate can restore normal glucose metabolism by enhancing insulin sensitivity,” and encourages NCCAM to expand its chromium research program.
- Congress Encourages Research on Chromium Picolinate and Diabetes
Bill signed into law by includes Report Language that recognizes that “chromium picolinate can restore normal glucose metabolism by enhancing insulin sensitivity,” and encourages NCCAM to expand its chromium research program.
- Congress Encourages Research on Chromium Picolinate and Diabetes
Bill signed into law by includes Report Language that recognizes that “chromium picolinate can restore normal glucose metabolism by enhancing insulin sensitivity,” and encourages NCCAM to expand its chromium research program.
- Nutrition 21 and XLHealth Announce Agreement to Make Diachrome Available to Physicians and People with Diabetes in Tennessee Chronic Care Improvement Program
Companies sign agreement in principle for a program that will make Diachrome(R) available to physicians for people with diabetes participating in the Center for Medicare and Medicaid (CMS) sponsored Chronic Care Improvement Program (CCIP) in Tennessee.
- Nutrition 21 and XLHealth Announce Agreement to Make Diachrome Available to Physicians and People with Diabetes in Tennessee Chronic Care Improvement Program
Companies sign agreement in principle for a program that will make Diachrome(R) available to physicians for people with diabetes participating in the Center for Medicare and Medicaid (CMS) sponsored Chronic Care Improvement Program (CCIP) in Tennessee.
- Nutrition 21 and XLHealth Announce Agreement to Make Diachrome Available to Physicians and People with Diabetes in Tennessee Chronic Care Improvement Program
Companies sign agreement in principle for a program that will make Diachrome(R) available to physicians for people with diabetes participating in the Center for Medicare and Medicaid (CMS) sponsored Chronic Care Improvement Program (CCIP) in Tennessee.
- Nutrition 21 and XLHealth Announce Agreement to Make Diachrome Available to Physicians and People with Diabetes in Tennessee Chronic Care Improvement Program
Companies sign agreement in principle for a program that will make Diachrome(R) available to physicians for people with diabetes participating in the Center for Medicare and Medicaid (CMS) sponsored Chronic Care Improvement Program (CCIP) in Tennessee.
- Nutrition 21 and XLHealth Announce Agreement to Make Diachrome Available to Physicians and People with Diabetes in Tennessee Chronic Care Improvement Program
Companies sign agreement in principle for a program that will make Diachrome(R) available to physicians for people with diabetes participating in the Center for Medicare and Medicaid (CMS) sponsored Chronic Care Improvement Program (CCIP) in Tennessee.
- Nutrition 21 Partners with Mandan, Hidatsa and Arikara Nation to Combat Epidemic of Type 2 Diabetes Among Tribal Members
Nutrition 21, Inc. and the Mandan, Hidatsa and Arikara Nation announce collaboration to conduct the first Diachrome® Physician Supervised Health Outcomes Initiative among Native Americans living with type 2 diabetes.
- Nutrition 21 Partners with Mandan, Hidatsa and Arikara Nation to Combat Epidemic of Type 2 Diabetes Among Tribal Members
Nutrition 21, Inc. and the Mandan, Hidatsa and Arikara Nation announce collaboration to conduct the first Diachrome® Physician Supervised Health Outcomes Initiative among Native Americans living with type 2 diabetes.
- Nutrition 21 Partners with Mandan, Hidatsa and Arikara Nation to Combat Epidemic of Type 2 Diabetes Among Tribal Members
Nutrition 21, Inc. and the Mandan, Hidatsa and Arikara Nation announce collaboration to conduct the first Diachrome® Physician Supervised Health Outcomes Initiative among Native Americans living with type 2 diabetes.
- FDA Approves First Qualified Health Claim for Chromium Picolinate and Risk of Type 2 Diabetes
FDA has concluded that there is credible evidence to support the following qualified health claim: “One small study suggests that chromium picolinate may reduce the risk of insulin resistance, and therefore possibly may reduce the risk of type 2 diabetes. FDA concludes, however, that the existence of such a relationship between chromium picolinate and either insulin resistance or type 2 diabetes is highly uncertain.”
- FDA Approves First Qualified Health Claim for Chromium Picolinate and Risk of Type 2 Diabetes
FDA has concluded that there is credible evidence to support the following qualified health claim: “One small study suggests that chromium picolinate may reduce the risk of insulin resistance, and therefore possibly may reduce the risk of type 2 diabetes. FDA concludes, however, that the existence of such a relationship between chromium picolinate and either insulin resistance or type 2 diabetes is highly uncertain.”
- FDA Approves First Qualified Health Claim for Chromium Picolinate and Risk of Type 2 Diabetes
FDA has concluded that there is credible evidence to support the following qualified health claim: “One small study suggests that chromium picolinate may reduce the risk of insulin resistance, and therefore possibly may reduce the risk of type 2 diabetes. FDA concludes, however, that the existence of such a relationship between chromium picolinate and either insulin resistance or type 2 diabetes is highly uncertain.”
- FDA Approves First Qualified Health Claim for Chromium Picolinate and Risk of Type 2 Diabetes
FDA has concluded that there is credible evidence to support the following qualified health claim: “One small study suggests that chromium picolinate may reduce the risk of insulin resistance, and therefore possibly may reduce the risk of type 2 diabetes. FDA concludes, however, that the existence of such a relationship between chromium picolinate and either insulin resistance or type 2 diabetes is highly uncertain.”
- Diachrome(R) Supplementation Associated with Potential Cost Savings of $52.9 Billion for People with Diabetes
economic analysis published in the August 2005 issue of the peer-reviewed journal Disease Management estimates the potential three-year cost savings that result from the decrease in HbA1C levels through the use of Diachrome, to be up to $52.9 billion for patients already diagnosed with diabetes plus a lifetime cost savings at $42 billion for newly diagnosed patients each year.
- Diachrome(R) Supplementation Associated with Potential Cost Savings of $52.9 Billion for People with Diabetes
economic analysis published in the August 2005 issue of the peer-reviewed journal Disease Management estimates the potential three-year cost savings that result from the decrease in HbA1C levels through the use of Diachrome, to be up to $52.9 billion for patients already diagnosed with diabetes plus a lifetime cost savings at $42 billion for newly diagnosed patients each year.
- Diachrome(R) Supplementation Associated with Potential Cost Savings of $52.9 Billion for People with Diabetes
economic analysis published in the August 2005 issue of the peer-reviewed journal Disease Management estimates the potential three-year cost savings that result from the decrease in HbA1C levels through the use of Diachrome, to be up to $52.9 billion for patients already diagnosed with diabetes plus a lifetime cost savings at $42 billion for newly diagnosed patients each year.
- PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes
Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes.
- PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes
Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes.
- PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes
Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes.
- PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes
Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes.
- PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes
Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes.
- PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes
Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes.
- PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes
Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes.
- Traditional Chinese Medicine For Diabetes Has Scientific Backing
A collaboration between Chinese, Korean, and Australian scientists at Sydney's Garvan Institute, has revealed that the natural plant product berberine could be a valuable new treatment for people suffering from type 2 diabetes.
- Traditional Chinese Medicine For Diabetes Has Scientific Backing
A collaboration between Chinese, Korean, and Australian scientists at Sydney's Garvan Institute, has revealed that the natural plant product berberine could be a valuable new treatment for people suffering from type 2 diabetes.
- Traditional Chinese Medicine For Diabetes Has Scientific Backing
A collaboration between Chinese, Korean, and Australian scientists at Sydney's Garvan Institute, has revealed that the natural plant product berberine could be a valuable new treatment for people suffering from type 2 diabetes.
- Traditional Chinese Medicine For Diabetes Has Scientific Backing
A collaboration between Chinese, Korean, and Australian scientists at Sydney's Garvan Institute, has revealed that the natural plant product berberine could be a valuable new treatment for people suffering from type 2 diabetes.
- Traditional Chinese Medicine For Diabetes Has Scientific Backing
A collaboration between Chinese, Korean, and Australian scientists at Sydney's Garvan Institute, has revealed that the natural plant product berberine could be a valuable new treatment for people suffering from type 2 diabetes.
- Sweet Success Targets Diabetic Market
Company to incorporate Integrity Nutraceuticals' Cinnulin PF(R) ingredient into its GlucaSafe(TM) beverage.
- Sweet Success Targets Diabetic Market
Company to incorporate Integrity Nutraceuticals' Cinnulin PF(R) ingredient into its GlucaSafe(TM) beverage.
- Sweet Success Targets Diabetic Market
Company to incorporate Integrity Nutraceuticals' Cinnulin PF(R) ingredient into its GlucaSafe(TM) beverage.
- GNC Introduces NutriSystem(R) Nourish(TM) Program
Company has announced a new relationship with NutriSystem, Inc. under which it is offering the NutriSystem program in 160 of its Philadelphia- and New York City-area markets and in other select GNC locations.
- GNC Introduces NutriSystem(R) Nourish(TM) Program
Company has announced a new relationship with NutriSystem, Inc. under which it is offering the NutriSystem program in 160 of its Philadelphia- and New York City-area markets and in other select GNC locations.
- GNC Introduces NutriSystem(R) Nourish(TM) Program
Company has announced a new relationship with NutriSystem, Inc. under which it is offering the NutriSystem program in 160 of its Philadelphia- and New York City-area markets and in other select GNC locations.
- Integrity Nutraceutical’s Cinnulin PF to Receive First-Ever INSIDER Scientific Excellence Award Presented at SupplySide West
Integrity Nutraceutical’s Cinnulin PF will receive the first INSIDER Scientific Excellence Award, to be presented at SupplySide West, Nov. 6 to 8 at The Venetian & The Sands Expo in Las Vegas.
- Integrity Nutraceutical’s Cinnulin PF to Receive First-Ever INSIDER Scientific Excellence Award Presented at SupplySide West
Integrity Nutraceutical’s Cinnulin PF will receive the first INSIDER Scientific Excellence Award, to be presented at SupplySide West, Nov. 6 to 8 at The Venetian & The Sands Expo in Las Vegas.
- Integrity Nutraceutical’s Cinnulin PF to Receive First-Ever INSIDER Scientific Excellence Award Presented at SupplySide West
Integrity Nutraceutical’s Cinnulin PF will receive the first INSIDER Scientific Excellence Award, to be presented at SupplySide West, Nov. 6 to 8 at The Venetian & The Sands Expo in Las Vegas.
- Integrity Nutraceutical’s Cinnulin PF to Receive First-Ever INSIDER Scientific Excellence Award Presented at SupplySide West
Integrity Nutraceutical’s Cinnulin PF will receive the first INSIDER Scientific Excellence Award, to be presented at SupplySide West, Nov. 6 to 8 at The Venetian & The Sands Expo in Las Vegas.
- Integrity Nutraceutical’s Cinnulin PF to Receive First-Ever INSIDER Scientific Excellence Award Presented at SupplySide West
Integrity Nutraceutical’s Cinnulin PF will receive the first INSIDER Scientific Excellence Award, to be presented at SupplySide West, Nov. 6 to 8 at The Venetian & The Sands Expo in Las Vegas.
- Chocolately Good Diabetes Care
In a study in the Journal of the American College of Cardiology, researchers found that cocoa can reverse some of the damage that diabetes has on blood vessels, possibly protecting against heart disease.
- Chocolately Good Diabetes Care
In a study in the Journal of the American College of Cardiology, researchers found that cocoa can reverse some of the damage that diabetes has on blood vessels, possibly protecting against heart disease.
- Chocolately Good Diabetes Care
In a study in the Journal of the American College of Cardiology, researchers found that cocoa can reverse some of the damage that diabetes has on blood vessels, possibly protecting against heart disease.
- Chocolately Good Diabetes Care
In a study in the Journal of the American College of Cardiology, researchers found that cocoa can reverse some of the damage that diabetes has on blood vessels, possibly protecting against heart disease.
- Chocolately Good Diabetes Care
In a study in the Journal of the American College of Cardiology, researchers found that cocoa can reverse some of the damage that diabetes has on blood vessels, possibly protecting against heart disease.
- Chocolately Good Diabetes Care
In a study in the Journal of the American College of Cardiology, researchers found that cocoa can reverse some of the damage that diabetes has on blood vessels, possibly protecting against heart disease.
- Vitamin K May Improve Insulin Resistance
Supplementing with vitamin K may improve insulin resistance in men, according to a new study published in Diabetes Care.
- Vitamin K May Improve Insulin Resistance
Supplementing with vitamin K may improve insulin resistance in men, according to a new study published in Diabetes Care.
- Vitamin K May Improve Insulin Resistance
Supplementing with vitamin K may improve insulin resistance in men, according to a new study published in Diabetes Care.
- New Study Shows Loquoro Plus™ Effective on Body Weight And Glucose Levels in Pre-Diabetic Subjects
The results of a new open-label clinical study assessing the effects of Loquoro Plus™ novel loquat leaf, 3% corosolic acid on body weight parameters and glucose levels have been announced by Ron Udell, President and CEO of OptiPure® Brand/ Kenko International.
- New Study Shows Loquoro Plus™ Effective on Body Weight And Glucose Levels in Pre-Diabetic Subjects
The results of a new open-label clinical study assessing the effects of Loquoro Plus™ novel loquat leaf, 3% corosolic acid on body weight parameters and glucose levels have been announced by Ron Udell, President and CEO of OptiPure® Brand/ Kenko International.
- New Study Shows Loquoro Plus™ Effective on Body Weight And Glucose Levels in Pre-Diabetic Subjects
The results of a new open-label clinical study assessing the effects of Loquoro Plus™ novel loquat leaf, 3% corosolic acid on body weight parameters and glucose levels have been announced by Ron Udell, President and CEO of OptiPure® Brand/ Kenko International.
- New Study Shows Loquoro Plus™ Effective on Body Weight And Glucose Levels in Pre-Diabetic Subjects
The results of a new open-label clinical study assessing the effects of Loquoro Plus™ novel loquat leaf, 3% corosolic acid on body weight parameters and glucose levels have been announced by Ron Udell, President and CEO of OptiPure® Brand/ Kenko International.
- New Study Shows Loquoro Plus™ Effective on Body Weight And Glucose Levels in Pre-Diabetic Subjects
The results of a new open-label clinical study assessing the effects of Loquoro Plus™ novel loquat leaf, 3% corosolic acid on body weight parameters and glucose levels have been announced by Ron Udell, President and CEO of OptiPure® Brand/ Kenko International.
- New Study Shows Loquoro Plus™ Effective on Body Weight And Glucose Levels in Pre-Diabetic Subjects
The results of a new open-label clinical study assessing the effects of Loquoro Plus™ novel loquat leaf, 3% corosolic acid on body weight parameters and glucose levels have been announced by Ron Udell, President and CEO of OptiPure® Brand/ Kenko International.
- New Study Shows Loquoro Plus™ Effective on Body Weight And Glucose Levels in Pre-Diabetic Subjects
The results of a new open-label clinical study assessing the effects of Loquoro Plus™ novel loquat leaf, 3% corosolic acid on body weight parameters and glucose levels have been announced by Ron Udell, President and CEO of OptiPure® Brand/ Kenko International.
- New Study Shows Loquoro Plus™ Effective on Body Weight And Glucose Levels in Pre-Diabetic Subjects
The results of a new open-label clinical study assessing the effects of Loquoro Plus™ novel loquat leaf, 3% corosolic acid on body weight parameters and glucose levels have been announced by Ron Udell, President and CEO of OptiPure® Brand/ Kenko International.
- New Study Shows Loquoro Plus™ Effective on Body Weight And Glucose Levels in Pre-Diabetic Subjects
The results of a new open-label clinical study assessing the effects of Loquoro Plus™ novel loquat leaf, 3% corosolic acid on body weight parameters and glucose levels have been announced by Ron Udell, President and CEO of OptiPure® Brand/ Kenko International.
- Nutrition 21 Reports that National Toxicology Program Studies Support the Safety of Chromium Picolinate
Nutrition 21, Inc., has reported that study results released by the National Toxicology Program (NTP) support the safety of short-term and long-term use of Chromium Picolinate. Multiple safety studies were performed in animals, including a two-year study using daily doses of chromium picolinate equivalent to 50,000 times the common human dose found in supplements.
- Nutrition 21 Reports that National Toxicology Program Studies Support the Safety of Chromium Picolinate
Nutrition 21, Inc., has reported that study results released by the National Toxicology Program (NTP) support the safety of short-term and long-term use of Chromium Picolinate. Multiple safety studies were performed in animals, including a two-year study using daily doses of chromium picolinate equivalent to 50,000 times the common human dose found in supplements.
- Nutrition 21 Reports that National Toxicology Program Studies Support the Safety of Chromium Picolinate
Nutrition 21, Inc., has reported that study results released by the National Toxicology Program (NTP) support the safety of short-term and long-term use of Chromium Picolinate. Multiple safety studies were performed in animals, including a two-year study using daily doses of chromium picolinate equivalent to 50,000 times the common human dose found in supplements.
- Nutrition 21 Reports that National Toxicology Program Studies Support the Safety of Chromium Picolinate
Nutrition 21, Inc., has reported that study results released by the National Toxicology Program (NTP) support the safety of short-term and long-term use of Chromium Picolinate. Multiple safety studies were performed in animals, including a two-year study using daily doses of chromium picolinate equivalent to 50,000 times the common human dose found in supplements.
- Nutrition 21 Reports that National Toxicology Program Studies Support the Safety of Chromium Picolinate
Nutrition 21, Inc., has reported that study results released by the National Toxicology Program (NTP) support the safety of short-term and long-term use of Chromium Picolinate. Multiple safety studies were performed in animals, including a two-year study using daily doses of chromium picolinate equivalent to 50,000 times the common human dose found in supplements.
- Nutrition 21 Reports that National Toxicology Program Studies Support the Safety of Chromium Picolinate
Nutrition 21, Inc., has reported that study results released by the National Toxicology Program (NTP) support the safety of short-term and long-term use of Chromium Picolinate. Multiple safety studies were performed in animals, including a two-year study using daily doses of chromium picolinate equivalent to 50,000 times the common human dose found in supplements.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
HAIFA, Israel, September 20, 2006 /PRNewswire-FirstCall via COMTEX/ -- Frutarom (UK:FRUT: news, chart, profile) has signed an exclusive global licensing agreement with D-Herb, of the NGT technological incubator in Nazareth, Israel, to produce and globally market a unique herbal extract, for the reduction and stabilization of glucose levels in the blood of diabetes and pre-diabetes patients. Frutarom intends to market and sell this unique extract, whose activity is supported by clinical trials that yielded excellent results, to the nutraceuticals, pharmaceuticals, functional food and health food industries, as part of its unique natural product portfolio.
Type II Diabetes has reached epidemic proportions and will continue to escalate due to a rise in obesity and an ageing population.
The number of diabetics in the world is estimated at 190 million, of which 20 million are in the USA. Forty percent (40%) of American diabetics use nutraceutical products in addition to conventional drug treatment. The American Diabetes Association estimates that an additional 41 million Americans suffer from pre-diabetes and recommends the use of nutraceuticals and food additives to reduce glucose levels in order to help prevent or postpone the onset of the disease. The US market for anti- diabetes natural products is estimated at US$ 50 million and last year grew 30%. This unique extract is the only clinically proven, natural product that reduces HbA1c levels in diabetes Type 2 patients (the most reliable test when measuring diabetes).
Ori Yehudai, President and Chief Executive Officer of Frutarom said, "Adding this unique, innovative product to Frutarom's natural extracts product portfolio aligns with Frutarom's strategy for rapid growth, with an emphasis on natural products for the fields of functional and health foods, as well as nutraceuticals and pharmaceuticals. Frutarom specializes in extracting active ingredients from botanicals and has a broad range of customers worldwide, including leading pharmaceutical, nutraceutical and food manufacturers. Frutarom will add the product to its portfolio of unique and innovative products and will begin marketing within several months."
Frutarom invests significant resources and considerable efforts to expand the range of natural products it produces and markets, with a special emphasis on functional food ingredients (food products combining unique ingredients adding health and dietary value) which delivers annual growth rates exceeding 10%.
Yehudai added that the cooperation with D-Herb is part of the company's broad strategy that aims to strengthen Frutarom's position as a leading supplier of natural products and functional food ingredients. As part of this strategy, Frutarom invests and cooperates with start-up companies, research institutes and universities that develop innovative and unique products and technologies associated with Frutarom's core activities. This activity supports and strengthens the ongoing in-house research and development activities conducted by the company's 21 R&D labs throughout the world.
According to Yehudai, "Frutarom is actively seeking new sources for breakthroughs and innovation and is involved in additional collaborations that will boost its research and development activity and significantly strengthen its product portfolio. Frutarom's partners can potentially benefit from the company's global presence and from its widespread sales and marketing network that includes offices in over 40 countries. Frutarom's partners will gain access to Frutarom's over 5,000 global and local customers in more than 100 countries, including market leaders in the food, nutraceutical, pharmaceutical and cosmetic industries. They can also profit from the company's extensive experience in industrial production, including in scaling up production processes and bringing products from the lab phase to commercial scale at Frutarom's 16 production facilities throughout the world."
Frutarom has a proven track record and exceptional capabilities in the field of botanical extracts from medicinal plants, along with a capacity for innovation in the production and marketing advanced raw materials based on scientific research. Together with the company's excellent access and long term acquaintance with the global food and nutraceuticals industries, and its extensive familiarity with their needs and requirements, these factors all provide the basis for Frutarom's advantages and for its positioning as a preferred partner for many of its customers worldwide in providing solutions combining superior health and taste.
Frutarom is a global public company traded on the Tel Aviv and London Stock Exchanges. The company develops, produces and markets flavors and ingredients used to produce food, beverages, pharmaceuticals, nutraceuticals, functional food and cosmetics. Frutarom produces and markets over 15,000 products to more than 5,000 customers in over 100 countries. Frutarom's sales totaled US$ 243.8 million in 2005 (growing 24% from the previous year), and its net profit totaled US$ 28 million (growing 50% from the previous year). Sales for the first half of 2006 totaled US$ 143.3 million, up 8.7% compared with the first half last year. Net profit for the first half of 2006 rose 14.4% to total US$ 17.4 million.
Frutarom operates through two Divisions: - The Flavors Division, which develops, produces and markets flavor compounds and food systems. - The Fine Ingredients Division, which develops, produces and markets natural flavor extracts, natural functional food ingredients, natural pharma/nutraceutical extracts, specialty essential oils and citrus products, and aroma chemicals. Frutarom's Vision is To Be the Preferred Partner for Tasty and Healthy Success! For further information, visit: www.frutarom.com |